M. Pastor

Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients

Eulàlia Sans-Serramitjana, Ester Fusté, Blanca Martínez‐Garriga et al. · Journal of Cystic Fibrosis · 2015 · 72 citations · Full text

Nanoencapsulated Colistin Sulfate, Nanobiotechnology, Cystic Fibrosis Patients +4

Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

Claudia Vairo, María Collantes, Gemma Quincoces et al. · International Journal of Pharmaceutics · 2019 · 48 citations

Tissue Engineering, Nanomedicine, Preclinical Safety +12

An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles

M. Pastor, Amaia Esquisabel, A Talavera et al. · International Journal of Pharmaceutics · 2013 · 30 citations

Vaccination, Mucosal Vaccination, Immunology +9

Safety of measles-mumps-rubella vaccine (MMR) in patients allergic to eggs

Inmaculada Cerecedo Carballo, M. Pastor, Borja Bartolomé et al. · Allergologia et Immunopathologia · 2007 · 23 citations · Full text

Stability study of sodium colistimethate-loaded lipid nanoparticles

María Moreno-Sastre, M. Pastor, Amaia Esquisabel et al. · Journal of Microencapsulation · 2016 · 22 citations

Nanoparticles, Nanotherapeutics, Engineering +16